AI is Accelerating Drug Discovery: McKernan
AI is speeding up drug discovery by analyzing health data and improving clinical trials, making medicine more personalized. While some parts of development can’t be rushed, the technology is already helping patients and researchers. This progress could lead to faster, more targeted treatments in the future.
Please make sure your browser supports JavaScript and cookies and that you are not blocking them from loading. For more information you can review our Terms of Service and Cookie Policy.
Bloomberg
